BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 7, 2006
View Archived Issues
Vical begins phase II study of DNA vaccine against CMV
Read More
Dr. Reddy's and Argenta collaborate on novel treatment for COPD
Read More
Avantogen and Innovate Oncology merge key oncology program
Read More
Altea and Teikoku Seiyaku sign Parkinson's transdermal patch agreement in Japan
Read More
Samaritan inlicenses drugs for mitochondrial disorders
Read More
Levulan BLU-U reduces acne lesions in phase II study
Read More
Elan updates progress
Read More
Antitumor and antiangiogenic potential of the phytochemical sulforaphane
Read More
In vitro and in vivo anticancer activity of KP-772
Read More
Targeting bombesin/GRP receptor pathways for sepsis
Read More
Enrollment completed in phase III chronic low back pain study of bicifadine
Read More
Halozyme begins study of subcutaneous morphine with Hylenex
Read More
Chromos Molecular Systems acquires Targeted Molecules
Read More
InterMune discontinues Actimmune ovarian cancer study
Read More
Zactima granted fast track designation for medullary thyroid carcinoma
Read More
Acuity studies Cand5 for wet AMD and diabetic macular edema
Read More
Ecopia cleared for Canadian phase I study of ECO-4601 in cancer patients
Read More
IND approved for phase I study of abiraterone acetate in advanced prostate cancer
Read More
Additional clinical responses seen in phase II talabostat studies
Read More
Androxal may restore normal testosterone level in testosterone deficient men
Read More
RotaTeq receives FDA approval
Read More
Recent Japan Tobacco patents disclose novel analgesic agents
Read More
Novel therapeutics for neurological disorders reported in recent patent literature
Read More
High intake of antioxidants may reduce the risk of AMD
Read More
Angiotensin II receptor antagonists evaluated for the treatment of hepatic fibrosis
Read More